FDA Food EnforcementHigh / 高

USPlabs OxyELITE Pro Ultra-Intense Thermo Advanced Formula DIETARY SUPPLEMENT Manufactured for USPlabs, LLC (Dallas, TX 75220), sold in the following sizes: 3 count; 90 count; and 180 count.

Recall F-1371-2014Published 2014-01-22Company USPlabs, LLC

Reason / 召回原因USPlabs, LLC received a 423(a), Notification of Opportunity to Initiate a Voluntary Recall, letter from FDA and is recalling products containing Aegeline and associated with serious adverse health events, namely serious liver damage or acute liver failure.

Distribution / 销售地区Worldwide distribution including the following Worldwide distribution including the following international countries: Ecuador, Russia, UAE, South America, Dominican Republic, Kuwait, Philippines, Indonesia, Egypt, Panama, China, and Argentina.

Code information / 批次信息3 count capsules, UPC #094922447883; 3 count capsules UPC #094922447876; 90 count capsules, UPC #094922395627; 180 count capsules UPC #094922447869

Official-information notice / 官方信息说明
This page organizes fields from the named agency record. It is not medical, legal, or food-safety advice. Always compare your package with the official notice.

Official record details

官方记录详情：以原始机构公告为准

Recall number / 召回编号

F-1371-2014

Classification / 风险等级

High / 高

Published / 发布时间

2014-01-22

Recalling firm / 召回企业

USPlabs, LLC

Product description / 产品描述

USPlabs OxyELITE Pro Ultra-Intense Thermo Advanced Formula DIETARY SUPPLEMENT Manufactured for USPlabs, LLC (Dallas, TX 75220), sold in the following sizes: 3 count; 90 count; and 180 count.

Product code / 产品代码

Not provided in the official record

Code information / 批次与代码信息

3 count capsules, UPC #094922447883; 3 count capsules UPC #094922447876; 90 count capsules, UPC #094922395627; 180 count capsules UPC #094922447869

Product quantity / 产品数量

1,065,783 units

Distribution / 销售地区

Worldwide distribution including the following Worldwide distribution including the following international countries: Ecuador, Russia, UAE, South America, Dominican Republic, Kuwait, Philippines, Indonesia, Egypt, Panama, China, and Argentina.

Reason for recall / 召回原因

USPlabs, LLC received a 423(a), Notification of Opportunity to Initiate a Voluntary Recall, letter from FDA and is recalling products containing Aegeline and associated with serious adverse health events, namely serious liver damage or acute liver failure.

Need the original notice?
Open the agency source for the complete official notice and any disposal, return, or contact instructions.

Open official source ↗

← Return to Recall Radar search / 返回搜索雷达

Last synchronized: 2026-08-09. Recall Radar does not replace agency guidance.